DRDina Ragab

Dina Ragab

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Dina Ragab has a total of 82 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Evaluation of CTLA-4 (+ 49A/G) polymorphism association with rheumatoid arthritis in Egyptian patients

    by Dina Ragab, Rasha Hammoda, Nermin El-Gharbawy, Ramy Salem

    Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) is an inhibitory molecule that has an essential role in T-cell homeostasis and self-tolerance because of its inhibitory signals. Genetic polymorphisms in the CTLA-4 gene have been associated with several autoimmune diseases. We aimed to assess the association between the CTLA-4 +49 A/G polymorphism (rs231775) and rheumatoid arthritis (RA) in Egyptian RA patients. The study included 104 RA patients and 81 apparently healthy control individuals. The polymorphism was assessed using restriction fragment-length polymorphism analysis. Genotype distribution was compared between patients and controls under different models of inheritance. Under the codominant model, RA patients showed a higher frequency of AG and GG genotypes compared to the control subjects (p=0.0092). Under the dominant model, RA patients showed a higher frequency of AG and GG genotypes grouped together compared to control subjects (p=0.0026). Under the over-dominant model, the AG genotype was more frequent in RA patients compared to control subjects (p= 0.0395). No association was observed between CTLA-4 polymorphism rs231775 and RA using the recessive model (p=0.1356). A significant association was observed between carrying the G allele and the presence of RA (p=0.0032). In conclusion, our findings showed a positive association between the CTLA-4 gene +49 A>G polymorphism and RA. However, discrepancies in literature reflect both ethnic variability in CTLA-4 gene polymorphisms as well as the complex pathogenesis of RA.


  • Open Access

    Frequency of ABCB1 C3435T Polymorphism in Rheumatoid Arthritis Patients; Relation to Methotrexate Responsiveness and Methotrexate Adverse Effects

    by Dina Ragab, Sara Eissa, Rania Ahmed, Abeer Ali, Samah Abd Alrahman, Shahira Al-Fedawy

    Background: Rheumatoid arthritis (RA) is an inflammatory disease requiring treatment by disease-modifying agents like methotrexate. C3435T is a single nucleotide polymorphism in the ABCB1 gene that affects the expression of the P-glycoprotein responsible for the efflux of several drugs from cells increasing both its action and toxicity. Objective: Examine the frequency of C3435T in RA patients and assess its influence on responsiveness to methotrexate treatment and occurrence of methotrexate adverse effects. Patients and Methods: Genotyping C3435T polymorphism was done by real-time polymerase chain reaction and the frequency of the polymorphism was assessed in a sample of 90 RA patients who have received methotrexate treatment and 90 healthy controls. The prevalence of the polymorphism was also assessed in responders to methotrexate compared to non-responders, and also in patients who suffered from methotrexate side effects compared to those who did not. Results: The CC was the most frequent genotype in patients (47.8%) while the CT was the most frequent in controls (43.3%), however, no association was found between the ABCB1 C3435T genotype and susceptibility to RA under the different genetic models (p>0.05). Even though the patients who responded to methotrexate had a higher frequency of the T allele (38.9%) compared to non-responders (27.8%), the genotype and allele frequency were not associated with response to methotrexate (p>0.05). Also, no association was observed between the frequency of the C3435T polymorphism and experiencing methotrexate-associated adverse effects (p>0.05). Conclusion: The C3435T polymorphism of the ABCB1 gene may not be a genetic risk factor for RA and does not affect responsiveness to methotrexate or affect the occurrence of adverse effects from the drug.


  • Open Access

    Risk factors of intensive care admission and mortality in a cohort of 111 Egyptian COVID-19 patients

    by Enas R Mohamed, Dina Ragab, Mohamed Taeimah, Heba Shaltoot

    It is important to understand and identify the different clinical characteristics of COVID-19 patients in order to better understand the disease process and determine the various factors associated with poor prognosis and mortality. Data from 111 COVID-19 patients were collected and retrospectively analyzed. The demographics, comorbidities, and laboratory test results of patients admitted to the intensive care unit (ICU) were compared with those admitted to the ward. Additionally, data obtained from patients who were discharged after treatment were compared with those who died at the hospital. Patients admitted to the ICU were older and presented with significantly higher levels of ferritin, lactate dehydrogenase (LDH), IL-6, c-reactive protein, and procalcitonin than those admitted to the ward. IL-6 level was an independent predictor of ICU admission. Likewise, the non-survivors were significantly older and had higher levels of LDH, d-dimer, IL-6, creatinine, blood urea nitrogen (BUN), and procalcitonin, and a higher prevalence of chronic kidney disease than those who were discharged from the hospital; increased age and high BUN levels were the independent predictors of mortality. This study identified high IL-6 level as a predictor of ICU admission and older age and high BUN levels as predictors of mortality in patients with COVID-19.

  • Open Access

    Increased expression of IL-37 correlates with TNF-α levels and disease stage in endometriosis patients

    by Dina Ragab, Ahmed Abbas, Ramy Salem

    Background: IL-37 is an anti-inflammatory cytokine that increases in several inflammatory diseases with the main inducing signal for its production being pro-inflammatory cytokines like TNF-α. We aimed to assess the correlation between peritoneal fluid levels of IL-37 and TNF-α in endometriosis patients and investigate their association with disease stage. Levels of IL-37 and TNF-α were assessed in peritoneal fluid of 50 patients with endometriosis and 23 endometriosis-free females using enzyme-linked immunosorbent assay. We also assessed serum levels of IL-37 using enzyme-linked immunosorbent assay and expression of IL-37 mRNA in peritoneal fluid cells using polymerase chain reaction. Results: Peritoneal fluid levels of IL-37 and TNF-α were higher in endometriosis patients than in control females. Also, levels were higher in patients with late endometriosis than patients with early endometriosis. In addition, serum levels of IL-37, as well as IL-37 mRNA expression in peritoneal fluid cells, were higher in patients than controls. In endometriosis patients, peritoneal fluid levels of IL-37 positively correlated with levels of TNF-α. Conclusion: Collectively, our results show increased levels of the anti-inflammatory cytokine IL-37 in endometriosis patients that correlate with levels of the pro-inflammatory cytokine TNF-α, one of the main signals for IL-37 production.


  • Krebs von den Lungen‐6, a promising marker in evaluating the severity of interstitial lung disease in Egyptian rheumatoid arthritis patients

    by Rasha Hammoda, Haitham Salah-ElDin, Nermin El-Gharbawy, Dina Ragab

    Krebs von den Lungen-6 (KL-6) is one of the mucins associated with interstitial lung disease. We aimed to assess the value of KL-6 as a marker for detecting the presence of interstitial lung disease in Egyptian rheumatoid arthritis patients and to evaluate its ability to assess severity in different grades of interstitial lung disease. The study included 89 rheumatoid arthritis patients; 64 patients with interstitial lung disease and 25 patients without interstitial lung disease. Serum levels of KL-6 were assessed using enzyme linked immunosorbent assay. Levels of KL-6 were higher in patients with interstitial lung disease compared to patients without interstitial lung disease (P< 0.001). KL-6 levels were significantly higher in grade 4 patients than those in grades 1 and 2. Also, KL-6 levels were significantly higher in grade 3 patients than those in grades 1 and 2. Kl-6 levels were also higher in grade 2 patients compared to grade 1 patients. Finally, no difference was observed between grade 4 patients and grade 3 patients. KL-6 levels were significantly higher in usual interstitial pneumonia pattern compared other patterns (P=0.015). In conclusion, KL-6 is a potential circulating biomarker that may have a substantial role in detecting the presence and evaluating the severity of interstitial lung disease among rheumatoid arthritis patients.


  • Open Access

    Interleukin 37 Levels in Relation to Serum Vitamin D Levels Among Ain Shams University Medical Students

    by Randa Reda Mabrouk, Afaf Abdelalim Mostafa, Dina Aly Mohamed Aly Ragab, Fouad Mohamed Fouad Zaki

    Background: The extraskeletal role of vitamin D is being increasingly recognized. This has important clinical implications, as vitamin D deficiency has reached epidemic proportions worldwide. Vitamin D has proposed anti-inflammatory properties as recent data suggests that low vitamin D concentrations are associated with increased levels of inflammatory markers. Interleukin-37(IL-37) is an IL1 family cytokine discovered in recent years and has 5 different isoforms. As an immunosuppressive factor, IL-37 can suppress excessive immune response .IL37 plays a role in protecting the body against endotoxin shock, ischemia reperfusion injury, autoimmune diseases, and cardiovascular diseases. In addition, IL-37 has a potential antitumor effect. IL-37 and its receptors may serve as novel targets for the study, diagnosis, and treatment of immune-related diseases and tumors. Aim of the Work: The aim of this study is to determine the relation between the level of interleukin-37 and 25-hydroxy Vitamin D among Ain Shams University medical students. Subjects and Methods: The study was conducted at Clinical Pathology Department, Ain Shams University Hospitals. Ninety individuals, from medical students of Ain Shams University who participated in the Nutritional Assessment of Ain Shams University Medical Students (NAMESASU) Project, were selected to be in the study. The study included 2 groups: Group I: included 45 subjects selected from the NAMES-ASU project with deficient vitamin D serum levels. Group II: included 45 subjects selected from the NAMES-ASU project with sufficient vitamin D serum levels. Results: There was a highly significant difference between the two groups regarding vitamin D levels. Serum IL-37 levels were significantly higher in group I subjects compared to group II subjects. No significant difference was observed between group I and group II regarding BMI, BFM, PBF and hsCRP. No significant difference was observed between the two subgroups regarding IL-37 levels and hsCRP levels. A highly significant negative correlation was observed between vitamin D levels and IL-37. A significant negative correlation was observed between hsCRP and vitamin D levels. However, no correlation was observed between hsCRP and IL-37 levels. Conclusion: Data from our study showed that present study denote that in case of vitamin D deficiency, irrespective of BMI, a subclinical state of inflammation may be present as reflected by the increased hsCRP levels and this state of inflammation might induce an increase in IL-37, an anti-inflammatory cytokine, in an attempt to reduce the inflammation.

  • Open Access

    Reliability of Plasma Von Willebrand Factor Antigen in Prediction of Oesophageal Varices in Pediatric and Adolescent Patients with Portal Hypertension

    by Lerine B Eldin, Asmaa W Abd Elaziz, Dina A Ragab, Karim A Abdelhady

    Background: Ruptured oesophageal varices (OVs) is a major cause of mortality in Portal hypertension (PHT) patients, It has been a great issue of interest and research to screen and early detect OVs via oesophageal varices non-invasive methods. Objective: The aim of this study was to assess the reliability of measuring plasma von willibrand factor antigen (VWF-Ag) for prediction of the occurrence of oesophageal varices in patients with portal hypertension. Subjects & Methods: This was a prospective cross-sectional study, done on 47 children with portal hypertension. The children were recruited from Pediatrics Hepatology clinic, Ain Shams University. Patient’s data was collected including age, sex, etiology and duration of PHT, along with medical treatment. Also an upper GIT endoscope, abdominal doppler ultrasound, and laboratory tests including measuring of plasma VWF-Ag were done to each patient. Then the children were divided based on their endoscopic findings into two groups; variceal group which included 37 patients, and a nonvariceal group which included 10 patients Results: The results of our study revealed an elevated plasma VWF-Ag in patients with oesophageal varices, whilst normal levels of plasma VWF-Ag in the non-variceal patients. In addition, there was a direct positive correlation between increased plasma VWF-Ag and the degree of oesophageal varices. Conclusion: Since the plasma VWF-Ag level correlates with the presence and degree of OVs, it can be used as a noninvasive indicator of the presence and degree of OVs, However, further studies using larger sample might be needed to support this.

  • Open Access

    Retrospective Analysis of the Prognostic Factors That Influence Treatment Response and Survival of Patients with Cancer of Unknown Primary

    by Zeinab Abdlelhafeez, Dina Ragab, Nervana Hussien, Fatma El – Tabakh

    Background: Cancers of unknown primary site (CUPs) are heterogeneous group of metastatic tumors for which a standardized diagnostic work-up could not recognize the site of origin at the time of diagnosis. Cancer registries around the world report the incidence of CUP in the range of 3%–5% of all malignancies, worldwide the overall age-standardized incidence per 100.000 people per year is 4–19 cases. CUP therefore ranks among the top 10 commonest malignancies. CUP occurs equally in both males and females, at average age 60 years old. Incidence of CUP in Egypt is 6.1%in males and 5.5% in females. Aim of the Work: to retrospectively identify the prognostic factors that influence treatment outcome and survival of patients diagnosed with cancer of unknown primary treated patients at Clinical Oncology departments at Ain Shams University Hospitals (ASUH) and Helwan University Hospitals by retrospective analysis. Patients and Methods: At the department of clinical oncology, Ain Shams University, 102 patients with cancer of unknown primary were identified in the period between January 2012 and December 2017, all patients data was collected and reviewed. The primary end point of this study is to identify different prognostic factors that influence treatment response and OS in 102 patients with CUP in the period from January 2012 to December 2017. Results: Patients with PS 1, with no comorbidities showed better treatment response, also Patients younger than 65year, presented with PS1, with no comorbidity had longer survival. Conclusion: CUP has a poor prognosis. Some prognostic factors that affect response to treatment and survival in these patients, which may be identified.

  • Open Access

    Evaluation of Natural Killer Cells in HCV Patients undergoing Hemodialysis

    by Yasser Ahmed Zeitoun, Rania HamdyEl-Kabarity, Tamer Wahid Elsaid, Dina Aly Mohamed Aly Ragab, Mariam Talaat Shaker Sedhom

    Background: Hepatitis C virus (HCV) is a hepatotropic virus and one of the major causes of liver disease and a potential cause of substantial morbidity and mortality worldwide. Patients on hemodialysis are at high risk for HCV, with frequency of infection several times higher than that in non-uremic patients. Natural killer (NK) cells are best appreciated for innate defense against viral infections and in tumor cell surveillance. Objective: To study the percentage of peripheral blood natural killer cells among chronic hepatitis C patients undergoing hemodialysis compared to chronic HCV patients with normal kidney functionsby flowcytometry immunophenotyping. Methodology: Frequency of CD3- CD56+ cells was assessed in two distinct groups. Group I: 35 chronic HCV patients with end stage renal disease and undergoing hemodialysis, group II: 35 age and sex matched chronic HCV patients with no kidney disease. Results: No significant difference was observed between HCV hemodialysis patients with ESRD and HCV patients with normal kidney function regarding the frequency of both NK cells (CD3CD56+) and NKT cells (CD3+CD56+). However, group I had significantly higher percentage of CD3+ cells than group II. Conclusion: no difference was found in this study between HCV patients on hemodialysis and HCV with normal kidney function regarding NK cell frequency. However, assessment of NK cell function in future studies might reveal differences.